We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Magic Mushroom Ingredient Classified as a 'Breakthrough Therapy' for Treatment-resistant Depression by FDA

News   Oct 25, 2018 | Original Press Release from COMPASS Pathways

 
Magic Mushroom Ingredient Classified as a 'Breakthrough Therapy' for Treatment-resistant Depression by FDA

Psilocybin was first extracted from the mushroom Psilocybe mexicana. By Alan Rockefeller [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia Commons

 
 
Advertisement
 

RELATED ARTICLES

Machine Learning Helps Identify Autism Blood Biomarkers

News

Using machine learning tools to analyze hundreds of proteins, UT Southwestern researchers have identified a group of biomarkers in blood that could lead to an earlier diagnosis of children with autism spectrum disorder (ASD) and, in turn, more effective therapies sooner.

READ MORE

Exploring the Personality of Marmoset Monkeys

News

An international team of behavioral biologists designed a set of tasks to assess personality of common marmosets.

READ MORE

127 Glaucoma Genes Identified in Largest Study of Its Kind

News

In the largest genome-wide association study of glaucoma comparing the genes of 34,179 people with the disease to 349,321 control subjects, an international consortium of researchers identified 44 new gene loci and confirmed 83 previously reported loci linked to glaucoma. Loci are considered "genetic street addresses," denoting a specific location on a gene.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE